nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Zonisamide—epilepsy syndrome	0.0968	0.153	CbGbCtD
Raloxifene—CYP2B6—Fosphenytoin—epilepsy syndrome	0.035	0.0552	CbGbCtD
Raloxifene—CYP2B6—Clobazam—epilepsy syndrome	0.0303	0.0479	CbGbCtD
Raloxifene—CYP2C8—Trimethadione—epilepsy syndrome	0.0282	0.0445	CbGbCtD
Raloxifene—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0265	0.0418	CbGbCtD
Raloxifene—CYP2B6—Carbamazepine—epilepsy syndrome	0.0251	0.0397	CbGbCtD
Raloxifene—CYP2B6—Primidone—epilepsy syndrome	0.0235	0.037	CbGbCtD
Raloxifene—CYP2B6—Phenytoin—epilepsy syndrome	0.0225	0.0356	CbGbCtD
Raloxifene—CYP2B6—Propofol—epilepsy syndrome	0.021	0.0332	CbGbCtD
Raloxifene—CYP2B6—Phenobarbital—epilepsy syndrome	0.0201	0.0317	CbGbCtD
Raloxifene—CYP2B6—Midazolam—epilepsy syndrome	0.0198	0.0313	CbGbCtD
Raloxifene—CYP2B6—Diazepam—epilepsy syndrome	0.019	0.0301	CbGbCtD
Raloxifene—CYP2C8—Carbamazepine—epilepsy syndrome	0.019	0.03	CbGbCtD
Raloxifene—CYP2C8—Primidone—epilepsy syndrome	0.0178	0.028	CbGbCtD
Raloxifene—CYP2C8—Phenytoin—epilepsy syndrome	0.0171	0.0269	CbGbCtD
Raloxifene—CYP2C8—Propofol—epilepsy syndrome	0.0159	0.0251	CbGbCtD
Raloxifene—CYP2C8—Phenobarbital—epilepsy syndrome	0.0152	0.024	CbGbCtD
Raloxifene—CYP2B6—Valproic Acid—epilepsy syndrome	0.015	0.0237	CbGbCtD
Raloxifene—CYP2C8—Diazepam—epilepsy syndrome	0.0144	0.0228	CbGbCtD
Raloxifene—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0123	0.0194	CbGbCtD
Raloxifene—CYP3A4—Felbamate—epilepsy syndrome	0.0114	0.018	CbGbCtD
Raloxifene—CYP3A4—Trimethadione—epilepsy syndrome	0.0114	0.018	CbGbCtD
Raloxifene—CYP2C8—Valproic Acid—epilepsy syndrome	0.0114	0.0179	CbGbCtD
Raloxifene—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0107	0.017	CbGbCtD
Raloxifene—CYP3A4—Clonazepam—epilepsy syndrome	0.00972	0.0153	CbGbCtD
Raloxifene—CYP3A4—Clobazam—epilepsy syndrome	0.00931	0.0147	CbGbCtD
Raloxifene—CYP3A4—Rufinamide—epilepsy syndrome	0.00792	0.0125	CbGbCtD
Raloxifene—CYP3A4—Carbamazepine—epilepsy syndrome	0.00772	0.0122	CbGbCtD
Raloxifene—CYP3A4—Primidone—epilepsy syndrome	0.00721	0.0114	CbGbCtD
Raloxifene—CYP3A4—Phenytoin—epilepsy syndrome	0.00692	0.0109	CbGbCtD
Raloxifene—CYP3A4—Propofol—epilepsy syndrome	0.00646	0.0102	CbGbCtD
Raloxifene—CYP3A4—Acetazolamide—epilepsy syndrome	0.00617	0.00974	CbGbCtD
Raloxifene—CYP3A4—Phenobarbital—epilepsy syndrome	0.00617	0.00974	CbGbCtD
Raloxifene—CYP3A4—Midazolam—epilepsy syndrome	0.00608	0.00961	CbGbCtD
Raloxifene—CYP3A4—Diazepam—epilepsy syndrome	0.00585	0.00923	CbGbCtD
Raloxifene—CYP3A4—Zonisamide—epilepsy syndrome	0.00571	0.00901	CbGbCtD
Raloxifene—CYP3A4—Valproic Acid—epilepsy syndrome	0.00461	0.00728	CbGbCtD
Raloxifene—CYP3A4—Topiramate—epilepsy syndrome	0.00416	0.00657	CbGbCtD
Raloxifene—HTR6—ganglion—epilepsy syndrome	0.003	0.105	CbGeAlD
Raloxifene—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.00164	1	CbGdCrCtD
Raloxifene—ESR2—hindbrain—epilepsy syndrome	0.0016	0.0557	CbGeAlD
Raloxifene—HTR6—forebrain—epilepsy syndrome	0.00126	0.0439	CbGeAlD
Raloxifene—HTR6—telencephalon—epilepsy syndrome	0.00116	0.0404	CbGeAlD
Raloxifene—Flavoxate—CHRM1—epilepsy syndrome	0.00111	0.551	CrCbGaD
Raloxifene—ESR1—hindbrain—epilepsy syndrome	0.00109	0.0382	CbGeAlD
Raloxifene—ESR2—brainstem—epilepsy syndrome	0.000916	0.0319	CbGeAlD
Raloxifene—Flavoxate—CHRM2—epilepsy syndrome	0.00091	0.45	CrCbGaD
Raloxifene—ESR2—forebrain—epilepsy syndrome	0.000884	0.0308	CbGeAlD
Raloxifene—ESR2—telencephalon—epilepsy syndrome	0.000813	0.0283	CbGeAlD
Raloxifene—HTR6—head—epilepsy syndrome	0.000721	0.0251	CbGeAlD
Raloxifene—CYP19A1—forebrain—epilepsy syndrome	0.000697	0.0243	CbGeAlD
Raloxifene—HTR6—nervous system—epilepsy syndrome	0.000684	0.0238	CbGeAlD
Raloxifene—HTR2B—forebrain—epilepsy syndrome	0.000684	0.0238	CbGeAlD
Raloxifene—HTR6—central nervous system—epilepsy syndrome	0.000658	0.0229	CbGeAlD
Raloxifene—SIGMAR1—telencephalon—epilepsy syndrome	0.00063	0.022	CbGeAlD
Raloxifene—HTR2B—telencephalon—epilepsy syndrome	0.000629	0.0219	CbGeAlD
Raloxifene—ESR1—brainstem—epilepsy syndrome	0.000628	0.0219	CbGeAlD
Raloxifene—ESR1—forebrain—epilepsy syndrome	0.000606	0.0211	CbGeAlD
Raloxifene—ESR1—telencephalon—epilepsy syndrome	0.000557	0.0194	CbGeAlD
Raloxifene—HTR6—brain—epilepsy syndrome	0.000523	0.0182	CbGeAlD
Raloxifene—ESR2—head—epilepsy syndrome	0.000506	0.0176	CbGeAlD
Raloxifene—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000495	0.0172	CbGeAlD
Raloxifene—ESR2—nervous system—epilepsy syndrome	0.00048	0.0167	CbGeAlD
Raloxifene—ESR2—central nervous system—epilepsy syndrome	0.000462	0.0161	CbGeAlD
Raloxifene—SIGMAR1—midbrain—epilepsy syndrome	0.000452	0.0158	CbGeAlD
Raloxifene—ESR2—cerebellum—epilepsy syndrome	0.000452	0.0157	CbGeAlD
Raloxifene—SIGMAR1—spinal cord—epilepsy syndrome	0.000441	0.0154	CbGeAlD
Raloxifene—AOX1—cerebellum—epilepsy syndrome	0.000435	0.0152	CbGeAlD
Raloxifene—CYP19A1—head—epilepsy syndrome	0.000399	0.0139	CbGeAlD
Raloxifene—HTR2B—head—epilepsy syndrome	0.000391	0.0136	CbGeAlD
Raloxifene—CYP19A1—nervous system—epilepsy syndrome	0.000378	0.0132	CbGeAlD
Raloxifene—HTR2B—nervous system—epilepsy syndrome	0.000371	0.0129	CbGeAlD
Raloxifene—ESR2—brain—epilepsy syndrome	0.000367	0.0128	CbGeAlD
Raloxifene—CYP19A1—central nervous system—epilepsy syndrome	0.000364	0.0127	CbGeAlD
Raloxifene—HTR2B—central nervous system—epilepsy syndrome	0.000357	0.0125	CbGeAlD
Raloxifene—AOX1—brain—epilepsy syndrome	0.000353	0.0123	CbGeAlD
Raloxifene—SIGMAR1—cerebellum—epilepsy syndrome	0.00035	0.0122	CbGeAlD
Raloxifene—ESR1—head—epilepsy syndrome	0.000347	0.0121	CbGeAlD
Raloxifene—ESR1—nervous system—epilepsy syndrome	0.000329	0.0115	CbGeAlD
Raloxifene—ESR1—central nervous system—epilepsy syndrome	0.000317	0.011	CbGeAlD
Raloxifene—ESR1—cerebellum—epilepsy syndrome	0.000309	0.0108	CbGeAlD
Raloxifene—CYP19A1—brain—epilepsy syndrome	0.000289	0.0101	CbGeAlD
Raloxifene—SIGMAR1—brain—epilepsy syndrome	0.000284	0.00991	CbGeAlD
Raloxifene—HTR2B—brain—epilepsy syndrome	0.000284	0.00988	CbGeAlD
Raloxifene—CYP2B6—head—epilepsy syndrome	0.000256	0.00893	CbGeAlD
Raloxifene—ESR1—brain—epilepsy syndrome	0.000251	0.00876	CbGeAlD
Raloxifene—CYP2B6—nervous system—epilepsy syndrome	0.000243	0.00847	CbGeAlD
Raloxifene—CYP2B6—central nervous system—epilepsy syndrome	0.000234	0.00815	CbGeAlD
Raloxifene—CYP2C8—brain—epilepsy syndrome	0.000207	0.00721	CbGeAlD
Raloxifene—CYP2B6—brain—epilepsy syndrome	0.000186	0.00647	CbGeAlD
Raloxifene—CYP3A4—nervous system—epilepsy syndrome	0.000183	0.00639	CbGeAlD
Raloxifene—CYP3A4—central nervous system—epilepsy syndrome	0.000177	0.00616	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.00013	0.000593	CcSEcCtD
Raloxifene—Dyspepsia—Carbamazepine—epilepsy syndrome	0.00013	0.000593	CcSEcCtD
Raloxifene—Urethral disorder—Gabapentin—epilepsy syndrome	0.00013	0.000592	CcSEcCtD
Raloxifene—Insomnia—Lamotrigine—epilepsy syndrome	0.00013	0.000589	CcSEcCtD
Raloxifene—Headache—Acetazolamide—epilepsy syndrome	0.000129	0.000586	CcSEcCtD
Raloxifene—Abdominal pain—Zonisamide—epilepsy syndrome	0.000128	0.000583	CcSEcCtD
Raloxifene—Body temperature increased—Zonisamide—epilepsy syndrome	0.000128	0.000583	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000128	0.000581	CcSEcCtD
Raloxifene—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000128	0.000581	CcSEcCtD
Raloxifene—Weight increased—Topiramate—epilepsy syndrome	0.000127	0.000577	CcSEcCtD
Raloxifene—Pain—Carbamazepine—epilepsy syndrome	0.000127	0.000576	CcSEcCtD
Raloxifene—Dizziness—Propofol—epilepsy syndrome	0.000127	0.000575	CcSEcCtD
Raloxifene—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000126	0.000575	CcSEcCtD
Raloxifene—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000126	0.000574	CcSEcCtD
Raloxifene—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000126	0.000573	CcSEcCtD
Raloxifene—Vertigo—Valproic Acid—epilepsy syndrome	0.000125	0.000569	CcSEcCtD
Raloxifene—Pneumonia—Topiramate—epilepsy syndrome	0.000125	0.000569	CcSEcCtD
Raloxifene—Flatulence—Pregabalin—epilepsy syndrome	0.000124	0.000564	CcSEcCtD
Raloxifene—Depression—Topiramate—epilepsy syndrome	0.000124	0.000564	CcSEcCtD
Raloxifene—Dizziness—Midazolam—epilepsy syndrome	0.000124	0.000562	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000124	0.000562	CcSEcCtD
Raloxifene—Abdominal pain—Clonazepam—epilepsy syndrome	0.000124	0.000561	CcSEcCtD
Raloxifene—Body temperature increased—Clonazepam—epilepsy syndrome	0.000124	0.000561	CcSEcCtD
Raloxifene—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000123	0.00056	CcSEcCtD
Raloxifene—Body temperature increased—Phenytoin—epilepsy syndrome	0.000123	0.000558	CcSEcCtD
Raloxifene—Pain—Lamotrigine—epilepsy syndrome	0.000122	0.000557	CcSEcCtD
Raloxifene—Nausea—Acetazolamide—epilepsy syndrome	0.000122	0.000556	CcSEcCtD
Raloxifene—Dizziness—Levetiracetam—epilepsy syndrome	0.000122	0.000555	CcSEcCtD
Raloxifene—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000122	0.000555	CcSEcCtD
Raloxifene—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000122	0.000555	CcSEcCtD
Raloxifene—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000122	0.000555	CcSEcCtD
Raloxifene—Cough—Valproic Acid—epilepsy syndrome	0.000122	0.000553	CcSEcCtD
Raloxifene—Vomiting—Propofol—epilepsy syndrome	0.000122	0.000553	CcSEcCtD
Raloxifene—Muscle spasms—Pregabalin—epilepsy syndrome	0.000121	0.000551	CcSEcCtD
Raloxifene—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000121	0.000551	CcSEcCtD
Raloxifene—Urinary tract infection—Topiramate—epilepsy syndrome	0.000121	0.00055	CcSEcCtD
Raloxifene—Conjunctivitis—Topiramate—epilepsy syndrome	0.000121	0.00055	CcSEcCtD
Raloxifene—Rash—Propofol—epilepsy syndrome	0.000121	0.000548	CcSEcCtD
Raloxifene—Dermatitis—Propofol—epilepsy syndrome	0.000121	0.000548	CcSEcCtD
Raloxifene—Headache—Propofol—epilepsy syndrome	0.00012	0.000545	CcSEcCtD
Raloxifene—Vomiting—Midazolam—epilepsy syndrome	0.000119	0.000541	CcSEcCtD
Raloxifene—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000119	0.000541	CcSEcCtD
Raloxifene—Myalgia—Valproic Acid—epilepsy syndrome	0.000119	0.000539	CcSEcCtD
Raloxifene—Chest pain—Valproic Acid—epilepsy syndrome	0.000119	0.000539	CcSEcCtD
Raloxifene—Arthralgia—Valproic Acid—epilepsy syndrome	0.000119	0.000539	CcSEcCtD
Raloxifene—Rash—Midazolam—epilepsy syndrome	0.000118	0.000536	CcSEcCtD
Raloxifene—Dizziness—Fosphenytoin—epilepsy syndrome	0.000118	0.000536	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000118	0.000536	CcSEcCtD
Raloxifene—Dermatitis—Midazolam—epilepsy syndrome	0.000118	0.000536	CcSEcCtD
Raloxifene—Vomiting—Levetiracetam—epilepsy syndrome	0.000118	0.000534	CcSEcCtD
Raloxifene—Headache—Midazolam—epilepsy syndrome	0.000117	0.000533	CcSEcCtD
Raloxifene—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000117	0.000532	CcSEcCtD
Raloxifene—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000117	0.000532	CcSEcCtD
Raloxifene—Diarrhoea—Diazepam—epilepsy syndrome	0.000117	0.000532	CcSEcCtD
Raloxifene—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000117	0.000532	CcSEcCtD
Raloxifene—Sinusitis—Topiramate—epilepsy syndrome	0.000117	0.000531	CcSEcCtD
Raloxifene—Rash—Levetiracetam—epilepsy syndrome	0.000117	0.00053	CcSEcCtD
Raloxifene—Dermatitis—Levetiracetam—epilepsy syndrome	0.000116	0.000529	CcSEcCtD
Raloxifene—Headache—Levetiracetam—epilepsy syndrome	0.000116	0.000526	CcSEcCtD
Raloxifene—Dizziness—Vigabatrin—epilepsy syndrome	0.000115	0.000522	CcSEcCtD
Raloxifene—Flatulence—Gabapentin—epilepsy syndrome	0.000114	0.000518	CcSEcCtD
Raloxifene—Nausea—Propofol—epilepsy syndrome	0.000114	0.000516	CcSEcCtD
Raloxifene—Vomiting—Fosphenytoin—epilepsy syndrome	0.000113	0.000515	CcSEcCtD
Raloxifene—Diarrhoea—Felbamate—epilepsy syndrome	0.000113	0.000515	CcSEcCtD
Raloxifene—Vertigo—Pregabalin—epilepsy syndrome	0.000113	0.000515	CcSEcCtD
Raloxifene—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Raloxifene—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Raloxifene—Dizziness—Diazepam—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Raloxifene—Infection—Valproic Acid—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Raloxifene—Syncope—Pregabalin—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Raloxifene—Rash—Fosphenytoin—epilepsy syndrome	0.000112	0.000511	CcSEcCtD
Raloxifene—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000112	0.000511	CcSEcCtD
Raloxifene—Rhinitis—Topiramate—epilepsy syndrome	0.000112	0.000509	CcSEcCtD
Raloxifene—Headache—Fosphenytoin—epilepsy syndrome	0.000112	0.000508	CcSEcCtD
Raloxifene—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000112	0.000507	CcSEcCtD
Raloxifene—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000111	0.000506	CcSEcCtD
Raloxifene—Nausea—Midazolam—epilepsy syndrome	0.000111	0.000505	CcSEcCtD
Raloxifene—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000111	0.000505	CcSEcCtD
Raloxifene—Muscle spasms—Gabapentin—epilepsy syndrome	0.000111	0.000505	CcSEcCtD
Raloxifene—Diarrhoea—Zonisamide—epilepsy syndrome	0.000111	0.000504	CcSEcCtD
Raloxifene—Pharyngitis—Topiramate—epilepsy syndrome	0.000111	0.000504	CcSEcCtD
Raloxifene—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000111	0.000503	CcSEcCtD
Raloxifene—Vomiting—Vigabatrin—epilepsy syndrome	0.000111	0.000502	CcSEcCtD
Raloxifene—Skin disorder—Valproic Acid—epilepsy syndrome	0.000111	0.000502	CcSEcCtD
Raloxifene—Urinary tract disorder—Topiramate—epilepsy syndrome	0.00011	0.000501	CcSEcCtD
Raloxifene—Oedema peripheral—Topiramate—epilepsy syndrome	0.00011	0.0005	CcSEcCtD
Raloxifene—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00011	0.0005	CcSEcCtD
Raloxifene—Cough—Pregabalin—epilepsy syndrome	0.00011	0.0005	CcSEcCtD
Raloxifene—Connective tissue disorder—Topiramate—epilepsy syndrome	0.00011	0.000499	CcSEcCtD
Raloxifene—Nausea—Levetiracetam—epilepsy syndrome	0.00011	0.000499	CcSEcCtD
Raloxifene—Rash—Vigabatrin—epilepsy syndrome	0.00011	0.000498	CcSEcCtD
Raloxifene—Dizziness—Felbamate—epilepsy syndrome	0.00011	0.000498	CcSEcCtD
Raloxifene—Dermatitis—Vigabatrin—epilepsy syndrome	0.00011	0.000498	CcSEcCtD
Raloxifene—Urethral disorder—Topiramate—epilepsy syndrome	0.00011	0.000498	CcSEcCtD
Raloxifene—Headache—Vigabatrin—epilepsy syndrome	0.000109	0.000495	CcSEcCtD
Raloxifene—Vomiting—Diazepam—epilepsy syndrome	0.000109	0.000495	CcSEcCtD
Raloxifene—Rash—Diazepam—epilepsy syndrome	0.000108	0.00049	CcSEcCtD
Raloxifene—Dermatitis—Diazepam—epilepsy syndrome	0.000108	0.00049	CcSEcCtD
Raloxifene—Arthralgia—Pregabalin—epilepsy syndrome	0.000107	0.000488	CcSEcCtD
Raloxifene—Myalgia—Pregabalin—epilepsy syndrome	0.000107	0.000488	CcSEcCtD
Raloxifene—Chest pain—Pregabalin—epilepsy syndrome	0.000107	0.000488	CcSEcCtD
Raloxifene—Dizziness—Zonisamide—epilepsy syndrome	0.000107	0.000487	CcSEcCtD
Raloxifene—Headache—Diazepam—epilepsy syndrome	0.000107	0.000487	CcSEcCtD
Raloxifene—Diarrhoea—Clonazepam—epilepsy syndrome	0.000107	0.000486	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000107	0.000484	CcSEcCtD
Raloxifene—Diarrhoea—Phenytoin—epilepsy syndrome	0.000106	0.000483	CcSEcCtD
Raloxifene—Nausea—Fosphenytoin—epilepsy syndrome	0.000106	0.000481	CcSEcCtD
Raloxifene—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000106	0.00048	CcSEcCtD
Raloxifene—Vomiting—Felbamate—epilepsy syndrome	0.000105	0.000479	CcSEcCtD
Raloxifene—Rash—Felbamate—epilepsy syndrome	0.000104	0.000475	CcSEcCtD
Raloxifene—Dermatitis—Felbamate—epilepsy syndrome	0.000104	0.000474	CcSEcCtD
Raloxifene—Vertigo—Gabapentin—epilepsy syndrome	0.000104	0.000472	CcSEcCtD
Raloxifene—Headache—Felbamate—epilepsy syndrome	0.000104	0.000472	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000104	0.000471	CcSEcCtD
Raloxifene—Flushing—Topiramate—epilepsy syndrome	0.000104	0.000471	CcSEcCtD
Raloxifene—Cardiac disorder—Topiramate—epilepsy syndrome	0.000104	0.000471	CcSEcCtD
Raloxifene—Syncope—Gabapentin—epilepsy syndrome	0.000104	0.000471	CcSEcCtD
Raloxifene—Dizziness—Clonazepam—epilepsy syndrome	0.000103	0.00047	CcSEcCtD
Raloxifene—Nausea—Vigabatrin—epilepsy syndrome	0.000103	0.000469	CcSEcCtD
Raloxifene—Vomiting—Zonisamide—epilepsy syndrome	0.000103	0.000469	CcSEcCtD
Raloxifene—Insomnia—Valproic Acid—epilepsy syndrome	0.000103	0.000468	CcSEcCtD
Raloxifene—Dizziness—Phenytoin—epilepsy syndrome	0.000103	0.000466	CcSEcCtD
Raloxifene—Rash—Zonisamide—epilepsy syndrome	0.000102	0.000465	CcSEcCtD
Raloxifene—Infection—Pregabalin—epilepsy syndrome	0.000102	0.000464	CcSEcCtD
Raloxifene—Dermatitis—Zonisamide—epilepsy syndrome	0.000102	0.000464	CcSEcCtD
Raloxifene—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000102	0.000464	CcSEcCtD
Raloxifene—Nausea—Diazepam—epilepsy syndrome	0.000102	0.000462	CcSEcCtD
Raloxifene—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000102	0.000462	CcSEcCtD
Raloxifene—Headache—Zonisamide—epilepsy syndrome	0.000102	0.000462	CcSEcCtD
Raloxifene—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000101	0.000461	CcSEcCtD
Raloxifene—Angiopathy—Topiramate—epilepsy syndrome	0.000101	0.000461	CcSEcCtD
Raloxifene—Shock—Pregabalin—epilepsy syndrome	0.000101	0.00046	CcSEcCtD
Raloxifene—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000101	0.000458	CcSEcCtD
Raloxifene—Cough—Gabapentin—epilepsy syndrome	0.000101	0.000458	CcSEcCtD
Raloxifene—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000101	0.000458	CcSEcCtD
Raloxifene—Dyspepsia—Valproic Acid—epilepsy syndrome	0.0001	0.000455	CcSEcCtD
Raloxifene—Skin disorder—Pregabalin—epilepsy syndrome	9.99e-05	0.000454	CcSEcCtD
Raloxifene—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.95e-05	0.000452	CcSEcCtD
Raloxifene—Vomiting—Clonazepam—epilepsy syndrome	9.94e-05	0.000452	CcSEcCtD
Raloxifene—Vomiting—Phenytoin—epilepsy syndrome	9.87e-05	0.000449	CcSEcCtD
Raloxifene—Rash—Clonazepam—epilepsy syndrome	9.86e-05	0.000448	CcSEcCtD
Raloxifene—Dermatitis—Clonazepam—epilepsy syndrome	9.85e-05	0.000447	CcSEcCtD
Raloxifene—Arthralgia—Gabapentin—epilepsy syndrome	9.84e-05	0.000447	CcSEcCtD
Raloxifene—Chest pain—Gabapentin—epilepsy syndrome	9.84e-05	0.000447	CcSEcCtD
Raloxifene—Myalgia—Gabapentin—epilepsy syndrome	9.84e-05	0.000447	CcSEcCtD
Raloxifene—Nausea—Felbamate—epilepsy syndrome	9.84e-05	0.000447	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.83e-05	0.000446	CcSEcCtD
Raloxifene—Vomiting—Oxcarbazepine—epilepsy syndrome	9.82e-05	0.000446	CcSEcCtD
Raloxifene—Dizziness—Carbamazepine—epilepsy syndrome	9.8e-05	0.000445	CcSEcCtD
Raloxifene—Diarrhoea—Lamotrigine—epilepsy syndrome	9.8e-05	0.000445	CcSEcCtD
Raloxifene—Headache—Clonazepam—epilepsy syndrome	9.79e-05	0.000445	CcSEcCtD
Raloxifene—Rash—Phenytoin—epilepsy syndrome	9.79e-05	0.000445	CcSEcCtD
Raloxifene—Dermatitis—Phenytoin—epilepsy syndrome	9.78e-05	0.000444	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.77e-05	0.000444	CcSEcCtD
Raloxifene—Rash—Oxcarbazepine—epilepsy syndrome	9.74e-05	0.000442	CcSEcCtD
Raloxifene—Pain—Valproic Acid—epilepsy syndrome	9.73e-05	0.000442	CcSEcCtD
Raloxifene—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.73e-05	0.000442	CcSEcCtD
Raloxifene—Headache—Phenytoin—epilepsy syndrome	9.73e-05	0.000442	CcSEcCtD
Raloxifene—Headache—Oxcarbazepine—epilepsy syndrome	9.67e-05	0.00044	CcSEcCtD
Raloxifene—Nausea—Zonisamide—epilepsy syndrome	9.63e-05	0.000438	CcSEcCtD
Raloxifene—Flatulence—Topiramate—epilepsy syndrome	9.58e-05	0.000435	CcSEcCtD
Raloxifene—Dizziness—Lamotrigine—epilepsy syndrome	9.47e-05	0.00043	CcSEcCtD
Raloxifene—Vomiting—Carbamazepine—epilepsy syndrome	9.42e-05	0.000428	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.37e-05	0.000426	CcSEcCtD
Raloxifene—Infection—Gabapentin—epilepsy syndrome	9.37e-05	0.000426	CcSEcCtD
Raloxifene—Muscle spasms—Topiramate—epilepsy syndrome	9.35e-05	0.000425	CcSEcCtD
Raloxifene—Rash—Carbamazepine—epilepsy syndrome	9.34e-05	0.000425	CcSEcCtD
Raloxifene—Dermatitis—Carbamazepine—epilepsy syndrome	9.34e-05	0.000424	CcSEcCtD
Raloxifene—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.31e-05	0.000423	CcSEcCtD
Raloxifene—Insomnia—Pregabalin—epilepsy syndrome	9.31e-05	0.000423	CcSEcCtD
Raloxifene—Nausea—Clonazepam—epilepsy syndrome	9.28e-05	0.000422	CcSEcCtD
Raloxifene—Headache—Carbamazepine—epilepsy syndrome	9.28e-05	0.000422	CcSEcCtD
Raloxifene—Shock—Gabapentin—epilepsy syndrome	9.28e-05	0.000422	CcSEcCtD
Raloxifene—Nervous system disorder—Gabapentin—epilepsy syndrome	9.25e-05	0.00042	CcSEcCtD
Raloxifene—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.24e-05	0.00042	CcSEcCtD
Raloxifene—Nausea—Phenytoin—epilepsy syndrome	9.22e-05	0.000419	CcSEcCtD
Raloxifene—Nausea—Oxcarbazepine—epilepsy syndrome	9.17e-05	0.000417	CcSEcCtD
Raloxifene—Skin disorder—Gabapentin—epilepsy syndrome	9.16e-05	0.000416	CcSEcCtD
Raloxifene—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.12e-05	0.000414	CcSEcCtD
Raloxifene—Vomiting—Lamotrigine—epilepsy syndrome	9.11e-05	0.000414	CcSEcCtD
Raloxifene—Rash—Lamotrigine—epilepsy syndrome	9.03e-05	0.00041	CcSEcCtD
Raloxifene—Dermatitis—Lamotrigine—epilepsy syndrome	9.02e-05	0.00041	CcSEcCtD
Raloxifene—Abdominal pain—Valproic Acid—epilepsy syndrome	9e-05	0.000409	CcSEcCtD
Raloxifene—Body temperature increased—Valproic Acid—epilepsy syndrome	9e-05	0.000409	CcSEcCtD
Raloxifene—Headache—Lamotrigine—epilepsy syndrome	8.97e-05	0.000408	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.88e-05	0.000404	CcSEcCtD
Raloxifene—Nausea—Carbamazepine—epilepsy syndrome	8.8e-05	0.0004	CcSEcCtD
Raloxifene—Pain—Pregabalin—epilepsy syndrome	8.8e-05	0.0004	CcSEcCtD
Raloxifene—Vertigo—Topiramate—epilepsy syndrome	8.74e-05	0.000397	CcSEcCtD
Raloxifene—Syncope—Topiramate—epilepsy syndrome	8.72e-05	0.000396	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.6e-05	0.000391	CcSEcCtD
Raloxifene—Loss of consciousness—Topiramate—epilepsy syndrome	8.55e-05	0.000388	CcSEcCtD
Raloxifene—Insomnia—Gabapentin—epilepsy syndrome	8.53e-05	0.000388	CcSEcCtD
Raloxifene—Nausea—Lamotrigine—epilepsy syndrome	8.51e-05	0.000387	CcSEcCtD
Raloxifene—Cough—Topiramate—epilepsy syndrome	8.49e-05	0.000386	CcSEcCtD
Raloxifene—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.41e-05	0.000382	CcSEcCtD
Raloxifene—Dyspepsia—Gabapentin—epilepsy syndrome	8.31e-05	0.000377	CcSEcCtD
Raloxifene—Myalgia—Topiramate—epilepsy syndrome	8.28e-05	0.000376	CcSEcCtD
Raloxifene—Arthralgia—Topiramate—epilepsy syndrome	8.28e-05	0.000376	CcSEcCtD
Raloxifene—Chest pain—Topiramate—epilepsy syndrome	8.28e-05	0.000376	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.22e-05	0.000374	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.15e-05	0.00037	CcSEcCtD
Raloxifene—Body temperature increased—Pregabalin—epilepsy syndrome	8.13e-05	0.00037	CcSEcCtD
Raloxifene—Abdominal pain—Pregabalin—epilepsy syndrome	8.13e-05	0.00037	CcSEcCtD
Raloxifene—Pain—Gabapentin—epilepsy syndrome	8.07e-05	0.000367	CcSEcCtD
Raloxifene—Infection—Topiramate—epilepsy syndrome	7.89e-05	0.000358	CcSEcCtD
Raloxifene—Shock—Topiramate—epilepsy syndrome	7.81e-05	0.000355	CcSEcCtD
Raloxifene—Diarrhoea—Valproic Acid—epilepsy syndrome	7.79e-05	0.000354	CcSEcCtD
Raloxifene—Nervous system disorder—Topiramate—epilepsy syndrome	7.78e-05	0.000354	CcSEcCtD
Raloxifene—Thrombocytopenia—Topiramate—epilepsy syndrome	7.77e-05	0.000353	CcSEcCtD
Raloxifene—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.72e-05	0.000351	CcSEcCtD
Raloxifene—Skin disorder—Topiramate—epilepsy syndrome	7.71e-05	0.00035	CcSEcCtD
Raloxifene—Hyperhidrosis—Topiramate—epilepsy syndrome	7.67e-05	0.000349	CcSEcCtD
Raloxifene—Dizziness—Valproic Acid—epilepsy syndrome	7.53e-05	0.000342	CcSEcCtD
Raloxifene—Abdominal pain—Gabapentin—epilepsy syndrome	7.46e-05	0.000339	CcSEcCtD
Raloxifene—Body temperature increased—Gabapentin—epilepsy syndrome	7.46e-05	0.000339	CcSEcCtD
Raloxifene—Vomiting—Valproic Acid—epilepsy syndrome	7.24e-05	0.000329	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.23e-05	0.000329	CcSEcCtD
Raloxifene—Insomnia—Topiramate—epilepsy syndrome	7.18e-05	0.000326	CcSEcCtD
Raloxifene—Rash—Valproic Acid—epilepsy syndrome	7.18e-05	0.000326	CcSEcCtD
Raloxifene—Dermatitis—Valproic Acid—epilepsy syndrome	7.17e-05	0.000326	CcSEcCtD
Raloxifene—Headache—Valproic Acid—epilepsy syndrome	7.13e-05	0.000324	CcSEcCtD
Raloxifene—Diarrhoea—Pregabalin—epilepsy syndrome	7.04e-05	0.00032	CcSEcCtD
Raloxifene—Dyspepsia—Topiramate—epilepsy syndrome	6.99e-05	0.000317	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.85e-05	0.000311	CcSEcCtD
Raloxifene—Dizziness—Pregabalin—epilepsy syndrome	6.8e-05	0.000309	CcSEcCtD
Raloxifene—Pain—Topiramate—epilepsy syndrome	6.79e-05	0.000308	CcSEcCtD
Raloxifene—Nausea—Valproic Acid—epilepsy syndrome	6.76e-05	0.000307	CcSEcCtD
Raloxifene—Vomiting—Pregabalin—epilepsy syndrome	6.54e-05	0.000297	CcSEcCtD
Raloxifene—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.49e-05	0.000295	CcSEcCtD
Raloxifene—Rash—Pregabalin—epilepsy syndrome	6.49e-05	0.000295	CcSEcCtD
Raloxifene—Dermatitis—Pregabalin—epilepsy syndrome	6.48e-05	0.000295	CcSEcCtD
Raloxifene—Diarrhoea—Gabapentin—epilepsy syndrome	6.46e-05	0.000293	CcSEcCtD
Raloxifene—Headache—Pregabalin—epilepsy syndrome	6.45e-05	0.000293	CcSEcCtD
Raloxifene—Body temperature increased—Topiramate—epilepsy syndrome	6.27e-05	0.000285	CcSEcCtD
Raloxifene—Abdominal pain—Topiramate—epilepsy syndrome	6.27e-05	0.000285	CcSEcCtD
Raloxifene—Dizziness—Gabapentin—epilepsy syndrome	6.24e-05	0.000283	CcSEcCtD
Raloxifene—Nausea—Pregabalin—epilepsy syndrome	6.11e-05	0.000278	CcSEcCtD
Raloxifene—Vomiting—Gabapentin—epilepsy syndrome	6e-05	0.000273	CcSEcCtD
Raloxifene—Rash—Gabapentin—epilepsy syndrome	5.95e-05	0.00027	CcSEcCtD
Raloxifene—Dermatitis—Gabapentin—epilepsy syndrome	5.94e-05	0.00027	CcSEcCtD
Raloxifene—Headache—Gabapentin—epilepsy syndrome	5.91e-05	0.000269	CcSEcCtD
Raloxifene—Nausea—Gabapentin—epilepsy syndrome	5.6e-05	0.000255	CcSEcCtD
Raloxifene—Diarrhoea—Topiramate—epilepsy syndrome	5.43e-05	0.000247	CcSEcCtD
Raloxifene—Dizziness—Topiramate—epilepsy syndrome	5.25e-05	0.000239	CcSEcCtD
Raloxifene—Vomiting—Topiramate—epilepsy syndrome	5.05e-05	0.000229	CcSEcCtD
Raloxifene—Rash—Topiramate—epilepsy syndrome	5e-05	0.000227	CcSEcCtD
Raloxifene—Dermatitis—Topiramate—epilepsy syndrome	5e-05	0.000227	CcSEcCtD
Raloxifene—Headache—Topiramate—epilepsy syndrome	4.97e-05	0.000226	CcSEcCtD
Raloxifene—Nausea—Topiramate—epilepsy syndrome	4.71e-05	0.000214	CcSEcCtD
Raloxifene—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.33e-06	8.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.33e-06	8.17e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HBEGF—epilepsy syndrome	9.31e-06	8.15e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9.3e-06	8.14e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NPY—epilepsy syndrome	9.28e-06	8.13e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.28e-06	8.13e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SIRT1—epilepsy syndrome	9.26e-06	8.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL12—epilepsy syndrome	9.14e-06	8.01e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BDKRB2—epilepsy syndrome	9.14e-06	8.01e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT3—epilepsy syndrome	9.14e-06	8e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—POMC—epilepsy syndrome	9.13e-06	7.99e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—VDR—epilepsy syndrome	9.12e-06	7.99e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PRKCB—epilepsy syndrome	9.1e-06	7.97e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—POMC—epilepsy syndrome	9.08e-06	7.95e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6ST—epilepsy syndrome	9.06e-06	7.94e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.01e-06	7.89e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JUNB—epilepsy syndrome	8.97e-06	7.86e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CNR1—epilepsy syndrome	8.97e-06	7.86e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	8.95e-06	7.84e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	8.95e-06	7.84e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—OXT—epilepsy syndrome	8.95e-06	7.84e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CRH—epilepsy syndrome	8.95e-06	7.84e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	8.95e-06	7.84e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PLCB1—epilepsy syndrome	8.94e-06	7.83e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADAM10—epilepsy syndrome	8.92e-06	7.82e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCL2—epilepsy syndrome	8.88e-06	7.78e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.77e-06	7.68e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR7—epilepsy syndrome	8.75e-06	7.67e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—H2AFX—epilepsy syndrome	8.65e-06	7.58e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HBEGF—epilepsy syndrome	8.5e-06	7.44e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	8.49e-06	7.43e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	8.49e-06	7.43e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—S100B—epilepsy syndrome	8.44e-06	7.39e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—epilepsy syndrome	8.4e-06	7.36e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SOCS3—epilepsy syndrome	8.36e-06	7.32e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	8.34e-06	7.31e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT3—epilepsy syndrome	8.34e-06	7.31e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDC42—epilepsy syndrome	8.34e-06	7.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	8.32e-06	7.29e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	8.32e-06	7.29e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.31e-06	7.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.31e-06	7.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.31e-06	7.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.31e-06	7.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.31e-06	7.28e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—POMC—epilepsy syndrome	8.29e-06	7.26e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	8.27e-06	7.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NR3C1—epilepsy syndrome	8.21e-06	7.19e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	8.17e-06	7.16e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CAT—epilepsy syndrome	8.16e-06	7.15e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADAM10—epilepsy syndrome	8.15e-06	7.14e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—SRC—epilepsy syndrome	8.12e-06	7.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCL2—epilepsy syndrome	8.11e-06	7.1e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	8.1e-06	7.09e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SST—epilepsy syndrome	8.1e-06	7.09e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	8.1e-06	7.09e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AVP—epilepsy syndrome	8.07e-06	7.07e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	8.03e-06	7.03e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	7.96e-06	6.97e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	7.94e-06	6.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.92e-06	6.94e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	7.91e-06	6.93e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.9e-06	6.92e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	7.89e-06	6.91e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.74e-06	6.78e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—S100B—epilepsy syndrome	7.7e-06	6.75e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HES1—epilepsy syndrome	7.63e-06	6.69e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SOCS3—epilepsy syndrome	7.63e-06	6.68e-05	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKT1—epilepsy syndrome	7.62e-06	6.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	7.61e-06	6.67e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.61e-06	6.67e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDC42—epilepsy syndrome	7.61e-06	6.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.6e-06	6.66e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.6e-06	6.66e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.6e-06	6.66e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	7.47e-06	6.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	7.47e-06	6.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	7.45e-06	6.52e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FYN—epilepsy syndrome	7.42e-06	6.5e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—H2AFX—epilepsy syndrome	7.4e-06	6.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MEF2C—epilepsy syndrome	7.38e-06	6.47e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPX1—epilepsy syndrome	7.38e-06	6.47e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AVP—epilepsy syndrome	7.37e-06	6.45e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.32e-06	6.41e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	7.29e-06	6.39e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	7.14e-06	6.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—YWHAZ—epilepsy syndrome	7.13e-06	6.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	7.08e-06	6.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.07e-06	6.19e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.07e-06	6.19e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NGF—epilepsy syndrome	7.05e-06	6.18e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	6.97e-06	6.1e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	6.95e-06	6.09e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	6.92e-06	6.06e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR5—epilepsy syndrome	6.86e-06	6.01e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	6.8e-06	5.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	6.79e-06	5.94e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	6.77e-06	5.93e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BCHE—epilepsy syndrome	6.77e-06	5.93e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	6.75e-06	5.91e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	6.74e-06	5.9e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	6.74e-06	5.9e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2A—epilepsy syndrome	6.72e-06	5.88e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	6.7e-06	5.87e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.65e-06	5.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.65e-06	5.82e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	6.51e-06	5.7e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AGT—epilepsy syndrome	6.47e-06	5.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.46e-06	5.66e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	6.46e-06	5.66e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	6.44e-06	5.64e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—S100B—epilepsy syndrome	6.42e-06	5.62e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	6.39e-06	5.6e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TSC2—epilepsy syndrome	6.38e-06	5.59e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AGT—epilepsy syndrome	6.37e-06	5.58e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TH—epilepsy syndrome	6.37e-06	5.58e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	6.35e-06	5.57e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOE—epilepsy syndrome	6.34e-06	5.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	6.34e-06	5.55e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.3e-06	5.52e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.3e-06	5.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	6.26e-06	5.49e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOE—epilepsy syndrome	6.24e-06	5.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AVP—epilepsy syndrome	6.14e-06	5.38e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	6.13e-06	5.37e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KDR—epilepsy syndrome	6.12e-06	5.36e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.06e-06	5.31e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	6.05e-06	5.3e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.01e-06	5.26e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.01e-06	5.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PRKCB—epilepsy syndrome	5.89e-06	5.16e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.88e-06	5.15e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6ST—epilepsy syndrome	5.86e-06	5.14e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	5.82e-06	5.1e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	5.82e-06	5.09e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HES1—epilepsy syndrome	5.8e-06	5.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.76e-06	5.05e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	5.76e-06	5.04e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BCHE—epilepsy syndrome	5.73e-06	5.02e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	5.7e-06	4.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.65e-06	4.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FYN—epilepsy syndrome	5.64e-06	4.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	5.62e-06	4.93e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	5.61e-06	4.92e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	5.58e-06	4.89e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.55e-06	4.86e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	5.47e-06	4.79e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—epilepsy syndrome	5.45e-06	4.77e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.43e-06	4.75e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	5.41e-06	4.74e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TH—epilepsy syndrome	5.39e-06	4.72e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	5.37e-06	4.71e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NGF—epilepsy syndrome	5.36e-06	4.7e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—epilepsy syndrome	5.36e-06	4.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	5.35e-06	4.69e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	5.31e-06	4.65e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.31e-06	4.65e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL2—epilepsy syndrome	5.25e-06	4.6e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAT—epilepsy syndrome	5.24e-06	4.59e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	5.22e-06	4.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.19e-06	4.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	5.11e-06	4.47e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	5.1e-06	4.47e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—epilepsy syndrome	5.04e-06	4.42e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.04e-06	4.41e-05	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—epilepsy syndrome	4.99e-06	4.37e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—epilepsy syndrome	4.97e-06	4.35e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	4.9e-06	4.29e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	4.85e-06	4.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AGT—epilepsy syndrome	4.85e-06	4.24e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	4.79e-06	4.2e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—epilepsy syndrome	4.75e-06	4.16e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF2—epilepsy syndrome	4.74e-06	4.15e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—epilepsy syndrome	4.74e-06	4.15e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KDR—epilepsy syndrome	4.65e-06	4.07e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.55e-06	3.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.55e-06	3.99e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	4.5e-06	3.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	4.48e-06	3.92e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	4.46e-06	3.91e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAT—epilepsy syndrome	4.44e-06	3.89e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RELA—epilepsy syndrome	4.4e-06	3.86e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	4.35e-06	3.81e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	4.33e-06	3.79e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	4.32e-06	3.78e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	4.32e-06	3.78e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—epilepsy syndrome	4.22e-06	3.7e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AGT—epilepsy syndrome	4.16e-06	3.64e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—epilepsy syndrome	4.08e-06	3.57e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—epilepsy syndrome	4.07e-06	3.57e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	4.02e-06	3.52e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.01e-06	3.52e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	4.01e-06	3.51e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	3.99e-06	3.5e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	3.97e-06	3.48e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	3.94e-06	3.45e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JUN—epilepsy syndrome	3.86e-06	3.38e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	3.75e-06	3.29e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.71e-06	3.25e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.66e-06	3.2e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	3.64e-06	3.19e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	3.62e-06	3.18e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.62e-06	3.17e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	3.61e-06	3.16e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.6e-06	3.15e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	3.52e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AGT—epilepsy syndrome	3.52e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—epilepsy syndrome	3.5e-06	3.06e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SRC—epilepsy syndrome	3.46e-06	3.03e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—epilepsy syndrome	3.45e-06	3.02e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	3.43e-06	3e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.37e-06	2.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RELA—epilepsy syndrome	3.35e-06	2.93e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.32e-06	2.91e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	3.28e-06	2.88e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.25e-06	2.84e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—epilepsy syndrome	3.19e-06	2.79e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	3.16e-06	2.77e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.09e-06	2.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.08e-06	2.69e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.08e-06	2.69e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	3.02e-06	2.64e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.96e-06	2.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.93e-06	2.57e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JUN—epilepsy syndrome	2.93e-06	2.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.9e-06	2.54e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TH—epilepsy syndrome	2.89e-06	2.53e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	2.85e-06	2.5e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	2.79e-06	2.44e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.7e-06	2.37e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SRC—epilepsy syndrome	2.63e-06	2.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.56e-06	2.24e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—epilepsy syndrome	2.51e-06	2.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.41e-06	2.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.38e-06	2.09e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.36e-06	2.07e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.32e-06	2.03e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—epilepsy syndrome	2.18e-06	1.91e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.15e-06	1.89e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.15e-06	1.88e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.96e-06	1.72e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.89e-06	1.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.85e-06	1.62e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	1.63e-06	1.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.59e-06	1.39e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.45e-06	1.27e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—epilepsy syndrome	1.4e-06	1.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.27e-06	1.11e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.19e-06	1.04e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.37e-07	5.58e-06	CbGpPWpGaD
